Skip to main content

Blog MHRA Inspectorate

Organisations:
Medicines and Healthcare products Regulatory Agency
MHRA Inspectorate

Good Clinical Practice Symposium 2020

Posted by: , Posted on: - Categories: Compliance matters, Events and symposia, Good clinical practice
Good Clinical Practice Symposium 2020

Between 11 and 14 February 2020, the MHRA hosted a week-long series of events as part of the Good Practice Symposia Week. The week concluded with the second joint MHRA GCP and US Food and Drug Administration (FDA) event following that hosted by the FDA in the USA in October 2018, and the first one hosted by the MHRA in the UK.

Good Laboratories Practice Symposium 2020

Posted by: , Posted on: - Categories: Compliance matters, Events and symposia, Good laboratory practice
The GLP Team at the 2020 symposium

Between 11 and 14 February 2020, the MHRA hosted a week-long series of events as part of the Good Practice Symposia Week. This included individual events from the GPvP, GCP and Laboratories Inspectorates where a host of regulators and delegates from across the globe came together. Second on the week-long agenda was the laboratories symposium, running on the 12th February and attended by 315 delegates.

How to manage temporary GDP process changes and risks through the COVID-19 pandemic

Posted by: , Posted on: - Categories: Compliance matters, Good distribution practice
Lady with a face mask and virus particles representing Covid infront of her

During the Covid-19 pandemic you may need to adjust how you operate. Such changes should be documented either as deviations, change controls or similar and incorporate quality risk management principles.

Advice for Good Laboratory Practice facilities in relation to coronavirus (COVID-19)

Posted by: , Posted on: - Categories: Compliance matters, Good laboratory practice
Diagram demonstrating that factors such as policy. standards, control, regulations and laws are all building blocks for compliance

It is recognised that there are potential challenges specific to GLP facilities and studies at this time. The aim of this post is to provide you with information that will enable a flexible but compliant approach during this period.

MHRA Good Practice (GxP) inspections during the COVID19 outbreak

Posted by: , Posted on: - Categories: Compliance matters, Good clinical practice, Good distribution practice, Good laboratory practice, Good manufacturing practice, Good pharmacovigilance practice
Virus particle

The COVID19 pandemic presents an unprecedented challenge to healthcare, the pharmaceutical industry’s supply chain and personnel movement. MHRA understands the impact of its work on industry, NHS and patients.

Related content and links

About the MHRA Inspectorate Blog

This blog shares the work of the Medicines and Healthcare products Regulatory Agency (MHRA) Inspectorate, by inspectors and those the Inspectorate works with.

Find out more

Categories

MHRA Inspectorate & Process Licensing Organogram

Find out more

We are hiring

Follow us on social media

Sign up and manage updates

Printing Posts

You can print blog posts using the keyboard shortcuts "Control P" or "Command P".

Other MHRA Blogs

MedRegs